Nocopi Technologies, Inc. entered into an agreement with Chief Operating Officer Terry Stovold under which he resigned from that role effective October 1, 2026. He will remain employed in a limited transitional capacity through July 1, 2029, receiving $8,000 per month and continuing to participate in the company’s medical and dental plans.
Upon completing the transition, Stovold is entitled to a $90,000 lump-sum payment, subject to withholding and his execution and non-revocation of a general release. If his employment ends before July 1, 2029, for a reason other than Cause, he remains entitled to the payment subject to the release condition; a termination for Cause ends compensation and benefits and eliminates the payment. His non-competition and non-solicitation obligations extend through July 1, 2031, or earlier termination of employment. The board expects to fill the COO vacancy but has not appointed a successor.
NOCOPI TECHNOLOGIES INC (NNUP) reported that Frost Gamma Investments Trust, a ten percent owner associated with Phillip Frost, acquired 21,930 shares of common stock on September 11, 2026. The shares were issued by Nocopi as consideration for advisory services under a Stock Purchase Agreement, bringing the trust’s indirect holdings to 1,511,642 shares. Phillip Frost disclaims beneficial ownership beyond any pecuniary interest.
NOCOPI TECHNOLOGIES INC (NNUP) director Eric Sites reported open-market purchases of the company’s common stock. He bought 1,000 shares on September 10, 2026 at $1.85 per share and 500 shares on September 11, 2026 at $1.80 per share, held as direct ownership. No Rule 10b5-1 trading plan is reported.
NOCOPI TECHNOLOGIES INC (NNUP) director Eric Sites purchased common stock in the company. On September 9, 2026, he bought 1,000 shares of common stock at $1.90 per share in an open market or private transaction and now holds 1,000 shares directly. No Rule 10b5-1 trading plan is reported for this transaction.
NOCOPI TECHNOLOGIES INC (NNUP) reported that Chief Executive Officer and director Matthew C. Winger purchased additional common stock in two open-market transactions. He bought 5,000 shares at $1.71 per share on August 18, 2026 and 200 shares at $1.80 per share on August 19, 2026, all held directly. These purchases were not reported as made under a Rule 10b5-1 trading plan.
Nocopi Technologies, Inc. reported sharply higher revenue but wider losses for the three and six months ended June 30, 2026. Total revenues were $961,012 for the quarter and $1,350,712 year-to-date, increases of approximately 167% and 61% compared with the prior-year periods, driven mainly by higher product and other sales, including contributions from the May 2026 Polymeric acquisition.
Gross profit rose to $357,381 for the quarter and $547,981 year-to-date, but gross margin declined as mix shifted away from higher-margin licenses and royalties toward lower-margin product sales. Operating expenses increased significantly to $925,113 for the quarter and $1,277,213 year-to-date, largely from higher professional and consulting fees, acquisition-related costs, and increased compensation, resulting in net losses of $471,927 for the quarter and $534,227 year-to-date. The company closed the $2,650,000 Polymeric U.S. business acquisition, adding goodwill and intangible assets, and ended the period with strong liquidity, including $10,687,269 in cash and cash equivalents and working capital of $12,688,837, with no income tax expense due to a full valuation allowance on deferred tax assets.
Nocopi Technologies, Inc. has provided additional financial detail on its May 18, 2026 acquisition of substantially all assets of Polymeric U.S., Inc., an inks and coatings business now operated through wholly owned subsidiary Polymeric Nocopi LLC.
The aggregate purchase price was $2,650,000, including $1,900,000 in cash, the assumption of specified liabilities and 500,000 shares of Nocopi common stock, with $150,000 of cash held back for working-capital and indemnification adjustments.
Polymeric generated $5,323,161 in 2025 sales and a net loss of $431,114, but earned net income of $145,879 on sales of $1,307,472 for the three months ended March 31, 2026. Pro forma, the combined company would have recorded 2025 revenue of $6,816,961 and a net loss of $586,014.
Nocopi Technologies, Inc. held its 2026 annual meeting of stockholders. Of 11,101,789 common shares outstanding as of April 24, 2026, 9,616,588 were represented in person or by proxy, establishing a quorum.
Stockholders elected Matthew C. Winger as a Class II director until the 2029 annual meeting, ratified Stephano Slack LLC as independent registered public accounting firm for the year ending December 31, 2026, and approved on a non-binding basis the compensation of the company’s named executive officers.
Nocopi Technologies has completed the acquisition of substantially all assets of Polymeric US for a total purchase price of $2.65 million, paid through $1.9 million in cash, assumed liabilities and 500,000 shares of common stock. Of the cash portion, $1.75 million was paid at closing, with $150,000 held back for working capital and indemnity claims.
Polymeric generated over $5 million in revenue for the twelve months ended March 31, 2026, and the combination more than triples Nocopi’s revenue base. Management expects the deal to be accretive to earnings within the year and to add new technologies, customers and production capacity from Polymeric’s 25,000 square-foot Kansas City facility.
In connection with the deal, Nocopi is conducting a private placement of 266,668 shares at $1.50 per share for approximately $400,000 in gross proceeds, including 133,334 shares each to Executive Director of Operations Gregory S. Babe and an affiliate of Horizon Kinetics. The company also entered into a registration rights agreement covering one investor’s placement shares.
Nocopi Technologies, Inc. reports Q1 2026 revenue of $389,700 and a net loss of $62,300, compared with net income of $25,500 a year earlier. Revenue fell about 19%, mainly because licenses, royalties and fees dropped to $100,700 from $190,300, while product sales were flat.
Gross margin slipped to roughly 49% as the mix shifted away from higher-margin licensing. Operating expenses were broadly stable at $352,100, and interest income of $105,200 partially offset the operating loss. Cash and cash equivalents increased to $11.9M, helped by a $400,000 private placement at $1.50 per share, leaving working capital of $13.3M and stockholders’ equity of $13.9M.